Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Amgen    AMGN

AMGEN (AMGN)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Amgen
Develops, manufactures and markets human therapeutic products based on cellular biology

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses.

The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.

Its products include aranesp, blincyto, corlanor, enbrel, epogen, imlygic, kyprolis, neulasta, neupogen, nplate, parsab, prolia, repatha, sensipar, vectibix, and xgeva.

The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Number of employees : 19 200 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Human Therapeutics21,662101.5%22,991101.4% +6.14%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States17,16780.5%18,32680.8% +6.75%
Rest of the World4,49521.1%4,66520.6% +3.78%
Managers
NameAgeSinceTitle
Robert Bradway542007Chairman & Chief Executive Officer
Esteban Santos492007Executive Vice President-Operations
David W. Meline, MBA592014Executive VP, Chief Financial & Accounting Officer
Sean E. Harper, PhD542002Executive Vice President-Research & Development
Paul R. Eisenberg, MD-2005Chief Medical Officer & Senior VP-Global Medical
Frank C. Herringer, MBA742004Independent Director
David Baltimore, PhD791999Independent Director
François de Carbonnel712008Independent Director
Rebecca M. Henderson PhD, MBA562009Independent Director
Ronald Sugar672010Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 729,674,773 728,624,385 99.9% 0 0.0% 99.9%
Shareholders
NameEquities%
Fidelity Management & Research Co. 54,781,871 7.51%
Capital Research & Management Co. (Global Investors) 53,746,966 7.37%
The Vanguard Group, Inc. 52,146,935 7.15%
BlackRock Fund Advisors 35,627,462 4.88%
SSgA Funds Management, Inc. 33,049,359 4.53%
PRIMECAP Management Co. 22,983,948 3.15%
Northern Trust Investments, Inc. 9,282,717 1.27%
ClearBridge Investments LLC 8,521,489 1.17%
Morgan Stanley Smith Barney LLC (Private Banking) 8,216,187 1.13%
Geode Capital Management LLC 7,851,032 1.08%
Holdings
NameEquities%Valuation
Cytokinetics, Inc. (CYTK) 1,984,9013.70%28,781,065 USD
Atara Biotherapeutics Inc (ATRA) 1,403,5014.59%23,227,942 USD
Advaxis, Inc. (ADXS) 3,047,4467.42%12,738,324 USD
Markets and indexes
- NASDAQ All Markets
- Nasdaq Global Select Market
- Nasdaq 100 / SP100, SP500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Stock Exchange Codes
- Bloomberg Code :  AMGN:US
- Reuters Code :  AMGN.O
- Datastream Code :  @AMGN
Company contact information
Amgen
1 Amgen Center Drive
US-CA 91320-1799 Thousand Oaks, California
États-Unis (les)

Phone : +1 805 447 1000
Fax : +1 805 447 1010
Internet : http://www.amgen.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
AMGEN25.17%135 858
JOHNSON & JOHNSON18.42%377 880
NOVARTIS13.23%225 650
ROCHE HOLDING LTD.5.20%217 022
PFIZER11.88%215 576
MERCK AND COMPANY7.68%172 423
SANOFI8.71%124 607
BAYER19.19%115 363
CELGENE CORPORATION17.89%108 637
BRISTOL-MYERS SQUIBB COMPANY11.72%105 250
GLAXOSMITHKLINE-2.94%98 264
NOVO NORDISK A/S16.92%96 545
ABBOTT LABORATORIES42.28%95 664
ELI LILLY AND COMPANY17.68%94 751
ASTRAZENECA15.54%86 638
ALLERGAN PLC-2.14%66 119
SHIRE-17.85%46 206
TAKEDA PHARMACEUTICAL CO LTD30.38%44 083
ASTELLAS PHARMA INC-7.07%27 260
JIANGSU HENGRUI MEDICINE CO LTD38.26%27 174
CHUGAI PHARMACEUTICAL CO LTD54.69%26 110
Connections : Amgen
Los Angeles Philharmonic Association
FdeC Services Ltd.
Cardax Pharma, Inc.
Ecofin Hedge Fund Ltd.
California Pacific Medical Center Foundation
National Bureau of Economic Research, Inc.
The Minnesota Opera Co.
BioVex Group, Inc.
Aegon U.S. Corp.
Ecofin Special Situations Funds Ltd.
Tuck School of Business at Dartmouth
Business & Environment Initiative
Charles Schwab Bank
Pearl Harbor Memorial Fund
Human Genome Organisation
The Column Group LLC
Onyx Pharmaceuticals, Inc.
Woodside Holdings Investment Management Pte Ltd.
Calimmune, Inc.
Groupe Foncier de l'Ile de France SA
Amgen Rockville, Inc.
Parc des Aulnais SA
University of Southern California
CEO Roundtable on Cancer, Inc.
UCLA Anderson School of Management
Harvard University
Pharmaceutical Research & Manufacturers of America
Harvard Business School
The Broad Institute, Inc.
BeyondTrust Software, Inc.
The Damon Runyon Cancer Research Foundation
Boys & Girls Clubs of America
Foundation for Biomedical Research
FasterCures
Alliance College-Ready Public Schools
The Broad Foundations
National Academy of Engineering
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem